# Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics

> **NCT00057499** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 12 (actual)

## Conditions studied

- Insulin-dependent Diabetes Mellitus
- Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** IBC-VS01
- **BIOLOGICAL:** IBC-VS01 placebo

## Key facts

- **NCT ID:** NCT00057499
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00057499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00057499, "Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00057499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*